Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis. Wyllie S, Thomas M, Patterson S, Crouch S, et al. Nature 2023 Jul 4. doi: 10.1038/s41586-023-06364.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wyllie S, Thomas M, Patterson S, Crouch S, et al. Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis. Nature 2023 Jul 4. doi: 10.1038/s41586-023-06364.
PMID: 37402863